Uncommon BCR-ABL kinase domain mutations in kinase inhibitor-resistant chronic myelogenous leukemia and Ph+ acute lymphoblastic leukemia show high rates of regression, suggesting weak selective effects

Dan Jones, Su S. Chen, Elias Jabbour, Mary Beth Rios, Hagop Kantarjian, Jorge Cortes

Research output: Contribution to journalLetterpeer-review

11 Scopus citations
Original languageEnglish (US)
Pages (from-to)5428-5429
Number of pages2
Issue number26
StatePublished - Jul 1 2010
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this